Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 7 (2010), Issue 3 (March)

1. Allele specific analysis of the ADRBK2 gene in lymphoblastoid cells from bipolar disorder patients.
   J Psychiatr Res, 44(4): 201-8. [Abstract] [Full-text]
2. Functional impact of biological rhythm disturbance in bipolar disorder.
   J Psychiatr Res, 44(4): 220-3. [Abstract] [Full-text]
3. Influence of neuregulin1 genotype on neural substrate of perceptual matching in children.
   Behav Genet, 40(2): 157-66. [Abstract] [Full-text]
4. Metabolic evidence of corticolimbic dysregulation in bipolar mania.
   Psychiatry Res, 181(2): 136-40. [Abstract] [Full-text]
5. Cerebellar telomere length and psychiatric disorders.
   Behav Genet, 40(2): 250-4. [Abstract] [Full-text]
6. Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study.
   ScientificWorldJournal, 10: 321-8. [Abstract] [Full-text]
7. Exploring differential prescribing between anti-epileptic drugs in epilepsy patients with a history of mood disorders.
   Pharmacoepidemiol Drug Saf, 19(3): 289-95. [Abstract] [Full-text]
8. Neurocognitive impairment and psychosis in bipolar I disorder during early remission from an acute episode of mood disturbance.
   J Clin Psychiatry, 71(2): 201-206. [Abstract] [Full-text]
9. Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
   Am J Psychiatry, 167(3): 289-97. [Abstract] [Full-text]
10. Psychiatric disorders in preschool offspring of parents with bipolar disorder: the Pittsburgh Bipolar Offspring Study (BIOS).
    Am J Psychiatry, 167(3): 321-30. [Abstract] [Full-text]
11. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-Month, randomized, placebo-controlled, double-blind trial.
    J Clin Psychiatry, 71(2): 130-137. [Abstract] [Full-text]
12. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
    J Clin Psychiatry, 71(2): 150-162. [Abstract] [Full-text]
13. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    J Clin Psychiatry, 71(2): 163-174. [Abstract] [Full-text]
14. Severe mental disorders in offspring with 2 psychiatrically ill parents.
    Arch Gen Psychiatry, 67(3): 252-7. [Abstract] [Full-text]
15. Rapid-cycling bipolar disorder: cross-national community study.
    Br J Psychiatry, 196: 217-25. [Abstract] [Full-text]
16. Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report.
    J Clin Psychiatry, 71(2): 194-200. [Abstract] [Full-text]
17. Course and impact of bipolar disorder in young patients.
    J Clin Psychiatry, 71(2): e05. [Abstract] [Full-text]
18. Perceived treatment effectiveness, medication compliance, and complementary and alternative medicine use among veterans with bipolar disorder.
    J Altern Complement Med, 16(3): 251-5. [Abstract] [Full-text]
19. Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression.
    Proc Natl Acad Sci U S A, 107(9): 4407-11. [Abstract] [Full-text]
20. Laterality effects in schizophrenia and bipolar disorder.
    Exp Brain Res, 201(2): 339-44. [Abstract] [Full-text]
21. Translin-associated factor X gene (TSNAX) may be associated with female major depressive disorder in the Japanese population.
    Neuromolecular Med, 12(1): 78-85. [Abstract] [Full-text]
22. Asenapine induces differential regional effects on serotonin receptor subtypes.
    J Psychopharmacol, 24(3): 341-8. [Abstract] [Full-text]
23. Low-dose quetiapine for patients with dysregulation of hyperthymic and cyclothymic temperaments.
    J Psychopharmacol, 24(3): 421-4. [Abstract] [Full-text]
24. Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.
    Schizophr Bull, 36(2): 271-88. [Abstract] [Full-text]
25. Ultrasonically determined thyroid volume and thyroid functions in lithium-naïve and lithium-treated patients with bipolar disorder: a cross-sectional and longitudinal study.
    Hum Psychopharmacol, 25(2): 174-8. [Abstract] [Full-text]
26. Atypical antipsychotics for acute manic and mixed episodes in children and adolescents with bipolar disorder: efficacy and tolerability.
    Drugs, 70(4): 433-42. [Abstract] [Full-text]
27. Suicide attempt characteristics may orientate toward a bipolar disorder in attempters with recurrent depression.
    J Affect Disord, 122(1): 53-9. [Abstract] [Full-text]
28. A genome-wide linkage study of bipolar disorder and co-morbid migraine: replication of migraine linkage on chromosome 4q24, and suggestion of an overlapping susceptibility region for both disorders on chromosome 20p11.
    J Affect Disord, 122(1): 14-26. [Abstract] [Full-text]
29. Response to intravenous antidepressant treatment by suicidal vs. nonsuicidal depressed patients.
    J Affect Disord, 122(1): 154-8. [Abstract] [Full-text]
30. The incidence of cardiovascular morbidity among patients with bipolar disorder: a population-based longitudinal study in Ontario, Canada.
    J Affect Disord, 122(1): 118-23. [Abstract] [Full-text]
31. Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    J Affect Disord, 122(1): 27-38. [Abstract] [Full-text]
32. Administration of inositol to a patient with bipolar disorder and psoriasis: a case report.
    Cases J, 3: 69. [Abstract] [Full-text]
33. Executive function in pediatric bipolar disorder and attention-deficit hyperactivity disorder: in search of distinct phenotypic profiles.
    Neuropsychol Rev, 20(1): 103-20. [Abstract] [Full-text]
34. Feasibility and diagnostic validity of the M-3 checklist: a brief, self-rated screen for depressive, bipolar, anxiety, and post-traumatic stress disorders in primary care.
    Ann Fam Med, 8(2): 160-9. [Abstract] [Full-text]
35. Bipolar disorder comorbid with alcoholism: a 1H magnetic resonance spectroscopy study.
    J Psychiatr Res, 44(5): 278-85. [Abstract] [Full-text]
36. Association of polymorphisms of the tryptophan hydroxylase 2 gene with risk for bipolar disorder or suicidal behavior.
    J Psychiatr Res, 44(5): 271-4. [Abstract] [Full-text]
37. Altered gene expression of histone deacetylases in mood disorder patients.
    J Psychiatr Res, 44(5): 263-70. [Abstract] [Full-text]
38. Magnetoencephalography in neuropsychiatry: ready for application?
    Curr Opin Psychiatry. [Abstract] [Full-text]
39. Effect of dopamine on intracellular sodium: A common pathway for pharmacological mechanism of action in bipolar illness.
    World J Biol Psychiatry, 11(2): 181-7. [Abstract] [Full-text]
40. Quetiapine monotherapy in bipolar I disorder: A 1-year stabilization in a woman having undergone bone marrow transplantation.
    World J Biol Psychiatry, 11(2): 519-21. [Abstract] [Full-text]
41. A single photon emission computerized tomography (SPECT) study of regional cerebral blood flow in bipolar disorder.
    World J Biol Psychiatry, 11(2): 334-43. [Abstract] [Full-text]
42. Anticonvulsant use, bipolar disorder, and risk of fracture among older adults in the veterans health administration.
    Am J Geriatr Psychiatry, 18(3): 245-55. [Abstract] [Full-text]
43. Do euthymic bipolar patients have normal cognitive functioning?
    Curr Opin Psychiatry. [Abstract] [Full-text]
44. Alteration of inhibitory circuits in the somatosensory cortex of Ts65Dn mice, a model for Down's syndrome.
    J Neural Transm, 117(4): 445-55. [Abstract] [Full-text]
45. Neurocognitive markers of psychosis in bipolar disorder: A meta-analytic study.
    J Affect Disord. [Abstract] [Full-text]
46. Are working memory deficits in bipolar disorder markers for psychosis?
    Neuropsychology, 24(2): 244-54. [Abstract] [Full-text]
47. A preliminary study of the neural mechanisms of frustration in pediatric bipolar disorder using magnetoencephalography.
    Depress Anxiety, 27(3): 276-86. [Abstract] [Full-text]
48. Electronic Medical Records as a Research Tool: Evaluating Topiramate Use at a Headache Center.
    Headache. [Abstract] [Full-text]
49. A novel analytical framework for dissecting the genetic architecture of behavioral symptoms in neuropsychiatric disorders.
    PLoS One, 5(3): e9714. [Abstract] [Full-text]
50. Valproate semisodium ER for migraine and cluster headache prophylaxis.
    Expert Opin Drug Metab Toxicol, 6(4): 495-504. [Abstract] [Full-text]
51. Psychodynamics of hypersexuality in children and adolescents with bipolar disorder.
    J Am Acad Psychoanal Dyn Psychiatry, 38(1): 27-45. [Abstract] [Full-text]
52. For what diagnoses are psychotropic medications being prescribed?: a nationally representative survey of physicians.
    CNS Drugs, 24(4): 319-26. [Abstract] [Full-text]
53. Is the increase of hypomanic stages during adolescence related to gender and developmental tasks?
    World J Biol Psychiatry, 11(3): 594-602. [Abstract] [Full-text]
54. Long-term efficacy of a psychological intervention program for patients with refractory bipolar disorder: a pilot study.
    Psychiatry Res, 176(2): 161-5. [Abstract] [Full-text]
55. Searching for new genetic risk factors for neuropsychiatric disorders in expression databases.
    J Mol Neurosci, 41(1): 193-7. [Abstract] [Full-text]
56. Integrative genome-wide association analysis of cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders.
    Mol Psychiatry. [Abstract] [Full-text]
57. Dynamic molecular and anatomical changes in the glucocorticoid receptor in human cortical development.
    Mol Psychiatry. [Abstract] [Full-text]
58. Update on the use of MR for assessment and diagnosis of psychiatric diseases.
    Radiology, 255(1): 23-41. [Abstract] [Full-text]
59. Patterns of antipsychotic medication use in Australia 2002-2007.
    Aust N Z J Psychiatry, 44(4): 372-7. [Abstract] [Full-text]
60. Psychopathology and symptom remission at adolescence among children with attention-deficit-hyperactivity disorder.
    Aust N Z J Psychiatry, 44(4): 323-32. [Abstract] [Full-text]
61. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients.
    Mol Psychiatry, 15(4): 384-92. [Abstract] [Full-text]
62. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.
    J Clin Psychiatry, 71(3): 255-61. [Abstract] [Full-text]
63. Comorbid substance use disorders among youth with bipolar disorder: opportunities for early identification and prevention.
    J Clin Psychiatry, 71(3): 348-58. [Abstract] [Full-text]
64. Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study.
    J Clin Psychiatry, 71(3): 296-303. [Abstract] [Full-text]
65. Long-term treatment of bipolar depression and other issues.
    J Clin Psychiatry, 71(3): e07. [Abstract] [Full-text]
66. Association between polymorphisms in the metallophosphoesterase (MPPE1) gene and bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 153(3): 830-6. [Abstract] [Full-text]
67. Identification of susceptibility loci at 7q31 and 9p13 for bipolar disorder in an isolated population.
    Am J Med Genet B Neuropsychiatr Genet, 153(3): 723-35. [Abstract] [Full-text]
68. MicroRNAs as a target for novel antipsychotics: a systematic review of an emerging field.
    Int J Neuropsychopharmacol, 13(3): 395-404. [Abstract] [Full-text]
69. Repeated effects of asenapine on adrenergic and cholinergic muscarinic receptors.
    Int J Neuropsychopharmacol, 13(3): 405-10. [Abstract] [Full-text]
70. ALP/Enigma PDZ-LIM domain proteins in the heart.
    J Mol Cell Biol, 2(2): 96-102. [Abstract] [Full-text]
71. Association study of ubiquitin-specific peptidase 46 (USP46) with bipolar disorder and schizophrenia in a Japanese population.
    J Hum Genet, 55(3): 133-6. [Abstract] [Full-text]
72. The rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusion.
    Med Care, 48(4): 372-9. [Abstract] [Full-text]
73. Symptomatic bradycardia with oral aripiprazole and oral ziprasidone.
    Ann Pharmacother, 44(4): 760-3. [Abstract] [Full-text]
74. Genetic variation in G72 correlates with brain activation in the right middle temporal gyrus in a verbal fluency task in healthy individuals.
    Hum Brain Mapp. [Abstract] [Full-text]
75. Intermediate: cognitive phenotypes in bipolar disorder.
    J Affect Disord, 122(3): 285-93. [Abstract] [Full-text]
76. Psychiatric reactions to isotretinoin in patients with bipolar disorder.
    J Affect Disord, 122(3): 306-8. [Abstract] [Full-text]
77. Midline brain abnormalities in established bipolar affective disorder.
    J Affect Disord, 122(3): 301-5. [Abstract] [Full-text]
78. Dysfunctional beliefs in bipolar disorder: hypomanic vs. depressive attitudes.
    J Affect Disord, 122(3): 294-300. [Abstract] [Full-text]
79. Is subclinical anxiety an endophenotype for bipolar I patients? A study from a Costa Rican sample.
    J Affect Disord, 122(3): 267-72. [Abstract] [Full-text]
80. Hippocampal function in schizophrenia and bipolar disorder.
    Psychol Med, 40(5): 761-70. [Abstract] [Full-text]
81. The study protocol of the Norwegian randomized controlled trial of electroconvulsive therapy in treatment resistant depression in bipolar disorder.
    BMC Psychiatry, 10: 16. [Abstract] [Full-text]
82. Improving 1H MRSI measurement of cerebral lactate for clinical applications.
    Psychiatry Res, 182(1): 40-7. [Abstract] [Full-text]
83. fMRI abnormalities in dorsolateral prefrontal cortex during a working memory task in manic, euthymic and depressed bipolar subjects.
    Psychiatry Res, 182(1): 22-9. [Abstract] [Full-text]
84. Correlation between amygdala volume and age in bipolar disorder - a systematic review and meta-analysis of structural MRI studies.
    Psychiatry Res, 182(1): 1-8. [Abstract] [Full-text]
85. Nuclear receptor rev-erb-{alpha} circadian gene variants and lithium carbonate prophylaxis in bipolar affective disorder.
    J Biol Rhythms, 25(2): 132-7. [Abstract] [Full-text]
86. Regaining mental capacity for treatment decisions following psychiatric admission: a clinico-ethical study.
    Psychol Med. [Abstract] [Full-text]
87. Association for Methodology and Documentation in Psychiatry Profiles Predict Later Risk for Criminal Behavior and Violent Crimes in Former Inpatients with Affective Disorder*
    J Forensic Sci. [Abstract] [Full-text]
88. Controversies concerning the diagnosis and treatment of bipolar disorder in children.
    Child Adolesc Psychiatry Ment Health, 4: 9. [Abstract] [Full-text]
89. Genetic variation in cholinergic muscarinic-2 receptor gene modulates M(2) receptor binding in vivo and accounts for reduced binding in bipolar disorder.
    Mol Psychiatry. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.